miR-196b-5p inhibits proliferation of Wharton's jelly umbilical cord stem cells

FEBS Open Bio. 2021 Jan;11(1):278-288. doi: 10.1002/2211-5463.13043. Epub 2020 Dec 8.

Abstract

Human umbilical cord mesenchymal stem cells can be obtained from different parts of the umbilical cord, including Wharton's jelly. Transplantation of Wharton's jelly umbilical cord stem cells (WJCMSCs) is a promising strategy for the treatment of various diseases. However, the molecular mechanisms underlying the proliferation of WJCMSCs are incompletely understood. Here, we report that overexpression of miR-196b-5p in WJCMSCs suppresses proliferation and arrests the cell cycle in G0/G1 phase, whereas knockdown of miR-196b-5p promotes WJCMSC proliferation and cell-cycle progression. Moreover, miR-196b-5p overexpression resulted in decreased levels of Cyclin A, Cyclin D, Cyclin E and cyclin-dependent kinases 2 and increased levels of p15INK4b , whereas miR-196b-5p knockdown had the opposite effects. In conclusion, our data suggests that miR-196b-5p inhibits WJCMSC proliferation by enhancing G0/G1-phase arrest.

Keywords: Wharton's jelly umbilical cord stem cells; cell cycle; cell proliferation; miR-196-5p.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Cell Differentiation
  • Cell Line
  • Cell Proliferation / genetics*
  • G1 Phase Cell Cycle Checkpoints / genetics
  • Humans
  • Mesenchymal Stem Cells / physiology*
  • MicroRNAs / metabolism*
  • Umbilical Cord / cytology
  • Wharton Jelly / cytology

Substances

  • MIRN196 microRNA, human
  • MicroRNAs